In Nantes, a team of researchers tested a vaccine on mice against house dust mite allergy, the most common in asthmatics.
The results of their research were recently published in a prestigious American scientific journal, the Journal of Allergy and Clinical Immunology. A team of Nantes researchers from Inserm (National Institute for Medical Research), at the University Hospital of Nantes, the INRA (National Institute for Agricultural Research), in collaboration with an Austrian lab, expressed its effective vaccine against house dust mite allergy, these tiny insects in the dust or mattresses.
“We injected mice with asthma risk called mite peptides, that is to say, very small pieces of allergenic proteins, explains Antoine Magnan, allergist, professor at INSERM at Nantes University Hospital. As for tetanus and flu, it causes a reaction of the immune system that protects against a later allergy The results are drastic.. these mice are then protected against asthma related to this allergy “
The researcher believes it will take “a decade without doubt” before moving to clinical trials in humans.
The mite allergy is the most commonly found in asthmatics.
